Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
5.24
-0.07 (-1.32%)
At close: Dec 5, 2025, 4:00 PM EST
5.28
+0.04 (0.76%)
After-hours: Dec 5, 2025, 7:59 PM EST
Altimmune Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Altimmune stock have an average target of 16.33, with a low estimate of 12 and a high estimate of 24. The average target predicts an increase of 211.64% from the current stock price of 5.24.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Altimmune stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +167.18% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +129.01% | Oct 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +129.01% | Oct 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +129.01% | Aug 13, 2025 |
| UBS | UBS | Strong Buy Maintains $26 → $24 | Strong Buy | Maintains | $26 → $24 | +358.02% | Aug 13, 2025 |
Financial Forecast
Revenue This Year
5.05K
from 20.00K
Decreased by -74.75%
Revenue Next Year
5.05K
from 5.05K
EPS This Year
-1.00
from -1.34
EPS Next Year
-1.23
from -1.00
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 21,000 | 21,000 | ||||
| Avg | 5,050 | 5,050 | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.0% | 315.8% | ||||
| Avg | -74.8% | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.02 | -1.08 | ||||
| Avg | -1.00 | -1.23 | ||||
| Low | -1.02 | -1.63 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.